Literature DB >> 16985847

Expectant management of prostate cancer.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2003        PMID： 16985847      PMCID： PMC1508370     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  11 in total

1.  Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.

Authors:  P C Walsh; P Marschke; D Ricker; A L Burnett
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

2.  Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis.

Authors:  M J Barry; P C Albertsen; M A Bagshaw; M L Blute; R Cox; R G Middleton; D F Gleason; H Zincke; E J Bergstralh; S J Jacobsen
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

Review 3.  Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

Authors:  H B Carter; J Sauvageot; P C Walsh; J I Epstein
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

4.  Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Authors:  H Ballentine Carter; Patrick C Walsh; Patricia Landis; Jonathan I Epstein
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

5.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

Authors:  Lars Holmberg; Anna Bill-Axelson; Fred Helgesen; Jaakko O Salo; Per Folmerz; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Christer Busch; Steg Nordling; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson; Bo Johan Norlén
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

6.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

7.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

Review 8.  Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening.

Authors:  P A Humphrey; D W Keetch; D S Smith; D L Shepherd; W J Catalona
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

9.  Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes.

Authors:  T A Stamey; A N Donaldson; C E Yemoto; J E McNeal; S Sözen; H Gill
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

10.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer.

Authors:  P H Gann; C H Hennekens; M J Stampfer
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.